1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Abemaciclib
Trade Name:
Verzenio
Manufacturer/Distributor:
Eli Lilly Canada
Classification:
Protein kinase inhibitor
Antineoplastic agent
ATC Class:
L01XE50 - abemaciclib
Status:
active
Notice of Compliance (yyyy/mm/dd):
2019/04/05
Date Marketed in Canada (yyyy/mm/dd):
2019/07/03
Presentation:
Tablet: 50 mg. DIN: 02487098
Tablet: 100 mg. DIN: 02487101
Tablet: 150 mg. DIN: 02487128
Tablet: 200 mg. DIN: 02487136
Comments:
For treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in adults.
Back to:
Drug Product Listings 
